Kimberlee C Drapkin's Net Worth
$816 Thousand
Who is Kimberlee C Drapkin?
Kimberlee C Drapkin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Jounce Therapeutics, Inc., Acumen Pharmaceuticals, Inc., KINETA, INC./DE, Graphite Bio, Inc., and EPIX Pharmaceuticals, Inc..
SEC CIK
Kimberlee C Drapkin's CIK is 0001340881
Past Insider Trading and Trends
2021 was Kimberlee C Drapkin's most active year for acquiring shares with 7 total transactions. Kimberlee C Drapkin's most active month to acquire stocks was the month of January. 2023 was Kimberlee C Drapkin's most active year for disposing of shares, totalling 12 transactions. Kimberlee C Drapkin's most active month to dispose stocks was the month of December. 2018 saw Kimberlee C Drapkin paying a total of $31,776.32 for 128,359 shares, this is the most they've acquired in one year. In 2021 Kimberlee C Drapkin cashed out on 53,127 shares for a total of $380,927.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jounce Therapeutics, Inc. No price found
President, CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -66.02K |
—
|
—
|
0
|
May 3
| |||
Form 4
| -17.59% | -14.10K |
$1.11 | -$15,661.22 | 66.02K |
Jan 9 - Jan 10
| |||
Form 4
| +52.27% | 27.5K |
—
|
—
| 80.11K |
Feb 1
| |||
Form 4
| -19.59% | -12.82K |
$6.88 | -$88,219.80 | 52.61K |
Jan 7 - Jan 10
| |||
Form 4
| +51.53% | 22.25K |
—
|
—
| 65.43K |
Feb 1
| |||
Form 4
| -22.73% | -12.70K |
$6.38 | -$316,603.61 | 43.18K |
Scheduled
|
Jan 20 - Jan 21
| ||
Form 4
| -9.44% | -5.83K |
$6.89 | -$40,141.72 | 55.88K |
Jan 7 - Jan 8
| |||
Form 4
| -10.45% | -7.20K |
$8.06 | -$58,032.00 | 61.71K |
Scheduled
|
Sep 1
| ||
Form 4
| -3.07% | -2.18K |
$4.71 | -$10,276.44 | 68.91K |
Aug 14 - Aug 18
| |||
Form 4
| +60.15% | 26.7K |
—
|
—
| 71.09K |
Feb 3
| |||
Form 4
| -5.58% | -2.62K |
$7.78 | -$20,414.72 | 44.39K |
Jan 7
| |||
Form 4
| -4.73% | -2.34K |
$3.99 | -$9,329.56 | 47.01K |
Aug 14 - Aug 16
| |||
Form 4
| +82.10% | 22.25K |
—
|
—
| 49.35K |
Feb 1
| |||
Form 4
| +88.19% | 12.7K |
$2.36 | $29,972.00 | 27.1K |
Aug 27
| |||
Form 4
|
∞
| 14.4K |
—
|
—
| 14.4K |
Aug 13
| |||
Form 4
| -100.00% | -1.51K |
$12.75 | -$129,923.35 |
0
|
Scheduled
|
Mar 8
| ||
Form 4
| -77.74% | -5.27K |
$21.42 | -$112,802.69 | 1.51K |
Scheduled
|
Mar 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acumen Pharmaceuticals, Inc. (ABOS) Snapshot price: $3.145
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KINETA, INC./DE (KA) Snapshot price: $2.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LENZ Therapeutics, Inc. (GRPH) Snapshot price: $2.915
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPIX Pharmaceuticals, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +501.56% | 270.45K |
$0.14 | -$27,137.46 | 324.37K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| +11.38% | 5.46K |
$0.46 | -$1,515.24 | 53.41K |
Feb 25
| |||
Form 4
| +335.90% | 36.95K |
$1.03 | -$26,941.71 | 47.95K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
∞
| 11K |
$0.98 | $10,780.00 | 11K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||